Change in Board of Directors
STENOCARE A/S (the “Company”) today announces that Ian Abramowitz has informed the Board of Directors that he is stepping down from his seat at the Board of STENOCARE, with immediate effect. STENOCARE wishes to thank Mr. Abramowitz for his contribution to the Company’s development in the past.
For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO Phone: +45 31770060 E-mail: firstname.lastname@example.org
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person above for publication on September 5, 2019.
STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot programme. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. The company offers high quality medical cannabis oil, which is produced by hygienic and high technology cultivation that comply with the strict Danish regulatory requirements. STENOCARE is also developing a separate production facility for the cultivation and production of medical cannabis at the company’s premises in Jutland, Denmark